Shirota et al. determined that IL-4 from T follicular helper cells downregulated antitumor immunity by inducing myeloid cells to differentiate into M2 macrophages [126], corroborating the cooperation of IL-4 and TAMs in modulating tumor progression in the TME. Here, IL4 is linked to neoplasm.